ArticleJournal of translational medicine2024

Multi-institutional prognostic modeling of survival outcomes in NSCLC patients treated with first-line immunotherapy using radiomics.

Sevinj Yolchuyeva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.